Scorpius Holdings, Inc. revenue for the last year amounted to 6.99 M USD, the most of which — 6.99 M USD — came from its highest performing source at the moment, Immunotherapies, the year earlier bringing 6.38 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Scorpius Holdings, Inc. 6.99 M USD, and the year before that — 6.38 M USD.